Mauna Kea Beach Hotel

Mauna Kea Technologies is a global medical device company that pioneered the field of functional optical biopsy. The company develops and markets Cellvizio, a multidisciplinary confocal laser endomicroscopy (CLE) platform that provides physicians with real-time, high-resolution microscopic images of tissue during endoscopic procedures. This technology is designed to improve the diagnosis and treatment of various cancers and inflammatory diseases by allowing for immediate cellular-level visualization. Mauna Kea Technologies focuses on applications in gastroenterology, pulmonology, and urology, aiming to reduce diagnostic uncertainty and optimize patient management. The company is headquartered in Paris and is publicly traded on Euronext.